Eyenovia Inc (EYEN) Rebrands as Hyperion DeFi (HYPD) Jul 2, 2025 08:02AM
Eyenovia Inc (EYEN) Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement Jun 30, 2025 08:00AM
Eyenovia Inc (EYEN) Announces Co-Branded Validator with Kinetiq Jun 25, 2025 08:33AM
Eyenovia Inc (EYEN) Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group Jun 18, 2025 08:33AM
Eyenovia (EYEN) Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy Jun 17, 2025 02:57PM


May 19, 2025 05:34PM Eyenovia Inc (EYEN) provides update on Betaliq merger
Apr 10, 2025 07:01AM Eyenovia Inc (EYEN) Provides Development Update on Optejet User Filled Device (UFD)
Feb 26, 2025 07:00AM Eyenovia Inc (EYEN) Regains Nasdaq Compliance
Feb 24, 2025 07:02AM Eyenovia Inc (EYEN) Announces Debt Restructuring Including Amendment to Senior Secured Debt
Feb 6, 2025 06:43AM H.C. Wainwright Reiterates Neutral Rating on Eyenovia (EYEN)
Jan 28, 2025 04:08PM Eyenovia Inc (EYEN) Announces 1:80 Reverse Share Split
Jan 6, 2025 07:01AM Eyenovia (EYEN) Engages Chardan as Advisor for Review of Strategic Alternatives
Jan 6, 2025 06:56AM Eyenovia Inc (EYEN) Halted, News Pending
Dec 6, 2024 08:00AM Eyenovia Inc (EYEN) Prices 20.09M Share Offering at $0.0969
Nov 25, 2024 08:00AM Eyenovia Inc (EYEN) Prices $1.3M Offering at $0.1076/sh
Nov 22, 2024 07:00AM Eyenovia Inc (EYEN) Provides Update on Restructuring Efforts
Nov 18, 2024 07:19AM H.C. Wainwright Downgrades Eyenovia (EYEN) to Neutral
Nov 15, 2024 09:24AM Brookline Capital Markets Downgrades Eyenovia (EYEN) to Hold
Nov 15, 2024 07:00AM Eyenovia Inc (EYEN) Provides Update on Phase 3 CHAPERONE Study
Nov 12, 2024 10:44PM Eyenovia Inc (EYEN) Tops Q3 EPS by 2c
Oct 23, 2024 07:00AM Eyenovia Inc (EYEN) Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet
Oct 1, 2024 05:15PM Eyenovia Inc (EYEN) Files $100M Mixed Shelf
Oct 1, 2024 07:03AM Eyenovia Inc (EYEN) Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device
Sep 27, 2024 08:31AM Eyenovia Inc (EYEN) Prices 8.7M Share Offering at $0.46/sh
Sep 26, 2024 07:01AM Eyenovia (EYEN) Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery
Sep 3, 2024 07:02AM Eyenovia Inc (EYEN) Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer
Aug 21, 2024 09:30AM Eyenovia (EYEN) Announces Pricing of $5.14 Million Public Offering
Aug 20, 2024 05:10PM Eyenovia Inc (EYEN) Announces Proposed Public Offering
Aug 13, 2024 06:10AM H.C. Wainwright Reiterates Buy Rating on Eyenovia (EYEN)
Aug 12, 2024 04:11PM Eyenovia Inc (EYEN) Misses Q2 EPS by 6c
Jul 30, 2024 08:00AM Eyenovia Inc (EYEN) & SGN Nanopharma Announce Collaboration Agreement to Develop Novel Treatment for Chronic Dry Eye Disease
Jul 23, 2024 07:01AM Eyenovia Inc (EYEN) and Senju Pharmaceutical Sign Collaboration Agreement for Potential New Treatment for Chronic Dry Eye Disease
Jul 1, 2024 06:50AM NovaBay Pharma (NBY) and Eyenovia (EYEN) Commence Co-Promotion Activities
Jun 28, 2024 08:00AM Eyenovia Inc (EYEN) Prices 7.56M Share Offering at $0.66/sh